Dana-Farber Cancer Institute CEO Wants To Tax Biopharma To Pay For The NIH

We are all sympathetic with getting significantly more funding for the NIH. After all, this can benefit us all. Let’s do so in a more creative fashion than levying a “tax”. Let’s try to find a win-win solution that we can all embrace.

Read the full post at Forbes - Pharma & Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive